Does HPV Vaccination Lower Cancer Risk in Males? - Summary - MDSpire
From the Journals

Does HPV Vaccination Lower Cancer Risk in Males?

A large real-world study found a lower incidence of any HPV-related cancer among vaccinated males

Share

A retrospective cohort study utilizing the TriNetX global database encompassing records from 190 million patients indicates that the 9-valent human papillomavirus (HPV) vaccine significantly reduces the incidence of HPV-related cancers in males aged 9 to 26. Of the over 3.5 million males analyzed, vaccinated individuals exhibited a 46% lower risk of developing head and neck, esophageal, penile, or anal cancers when compared to their unvaccinated counterparts. While the study demonstrates a strong association, limitations such as reliance on administrative coding and potential misclassification were noted. Researchers advocate for sex-neutral HPV vaccination programs, highlighting the need to include young males in vaccination initiatives.

Original Source(s)

Does HPV Vaccination Lower Cancer Risk in Males?

  • by Kerri Miller

  • April 17, 2026

Related Content

Planning for Succession Before It's Too Late

Isabelle Bibet-Kalinyak, JD, MBA, and Rajesh U. Kothari, MBA discuss how an aging physician population and the changing business of health care make planning for the future an imperative.

  • April 11, 2026

  • 10 min
Eight Competencies Defined for Family Physicians

Analysis of 34 studies identifies core competency gaps and emphasizes evolving scope of family medicine

Maryland orders Cigna to stop automatic downcoding, issues $80,000 fine 

Maryland’s Insurance Administration has fined health insurance company Cigna $80,000.